Anti-Inflammatory Effects of Traditional Chinese Medicines against Ischemic Injury in In Vivo Models of Cerebral Ischemia

Evidence-based Complementary and Alternative Medicine

Volumn 2016, Issue , 2016, Pages

  Cheng, Chin Yi ^a,b   Lee, Yu Chen ^c,d  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b Department of Chinese Medicine Hui Sheng Hospital   (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CHINESE DRUG; CYTOKINE; INTERCELLULAR ADHESION MOLECULE 1; MATRIX METALLOPROTEINASE; MEDIATOR COMPLEX; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR;

ANTIINFLAMMATORY ACTIVITY; BLOOD BRAIN BARRIER; BRAIN INJURY; BRAIN ISCHEMIA; CHINESE HERB; CHINESE MEDICINE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE EXACERBATION; DOWN REGULATION; DRUG FORMULATION; DRUG MECHANISM; ENZYME SYNTHESIS; IN VIVO STUDY; MACROPHAGE; MEDIATOR RELEASE; MICROGLIA; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; REVIEW; UPREGULATION;

EID: 84989337962     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2016/5739434     Document Type: Review

References (120)

1. A. Siniscalchi, L. Gallelli, G. Malferrari et al., "Cerebral stroke injury: the role of cytokines and brain inflammation," Journal of Basic and Clinical Physiology and Pharmacology, vol. 25, no. 2, pp. 131-137, 2014.
2. R. Jin, L. Liu, S. Zhang, A. Nanda, and G. Li, "Role of inflammation and its mediators in acute ischemic stroke," Journal of Cardiovascular Translational Research, vol. 6, no. 5, pp. 834-851, 2013.
3. R. Jin, G. Yang, and G. Li, "Inflammatory mechanisms in ischemic stroke: role of inflammatory cells," Journal of Leukocyte Biology, vol. 87, no. 5, pp. 779-789, 2010.
4. R.-D. Cheng, J.-J. Ren, Y.-Y. Zhang, and X.-M. Ye, "P2X4 receptors expressed on microglial cells in post-ischemic inflammation of brain ischemic injury," Neurochemistry International, vol. 67, no. 1, pp. 9-13, 2014.
5. M. K. Tobin, J. A. Bonds, R.D.Minshall, D. A. Pelligrino, F.D. Testai, and O. Lazarov, "Neurogenesis and inflammation after ischemic stroke: what is known and where we go from here," Journal of Cerebral Blood Flow and Metabolism, vol. 34, no. 10, pp. 1573-1584, 2014.
6. J. Y. Kim, M. Kawabori, and M. A. Yenari, "Innate inflammatory responses in stroke: mechanisms and potential therapeutic targets," Current Medicinal Chemistry, vol. 21, no. 18, pp. 2076-2097, 2014.
7. S. E. Lakhan, A. Kirchgessner, and M. Hofer, "Inflammatory mechanisms in ischemic stroke: therapeutic approaches," Journal of Translational Medicine, vol. 7, article 97, 2009.
8. E.-Y. Cho, S.-J. Lee, K.-W. Nam et al., "Amelioration of oxygen and glucose deprivation-induced neuronal death by chloroform fraction of bay leaves (Laurus nobilis)," Bioscience, Biotechnology and Biochemistry, vol. 74, no. 10, pp. 2029-2035, 2010.
9. A. Simats, T. García-Berrocoso, and J. Montaner, "Neuroinflammatory biomarkers: from stroke diagnosis and prognosis to therapy," Biochimica et Biophysica Acta - Molecular Basis of Disease, vol. 1862, no. 3, pp. 411-424, 2016.
10. J. Galea and D. Brough, "The role of inflammation and interleukin-1 in acute cerebrovascular disease," Journal of Inflammation Research, vol. 6, no. 1, pp. 121-128, 2013.
11. V. L. Feigin, "Herbal medicine in stroke: does it have a future?" Stroke, vol. 38, no. 6, pp. 1734-1736, 2007.
12. Z. Liu, P. Li, D. Zhao, H. Tang, and J. Guo, "Anti-inflammation effects of cordyceps sinensis mycelium in focal cerebral ischemic injury rats," Inflammation, vol. 34, no. 6, pp. 639-644, 2011.
13. K. Sun, J. Fan, and J. Han, "Ameliorating effects of traditional Chinese medicine preparation, Chinese materia medica and active compounds on ischemia/reperfusion-induced cerebral microcirculatory disturbances and neuron damage," Acta Pharmaceutica Sinica B, vol. 5, no. 1, pp. 8-24, 2015.
14. S. Rivest, "Regulation of innate immune responses in the brain," Nature Reviews Immunology, vol. 9, no. 6, pp. 429-439, 2009.
15. H.W.Morrison and J. A. Filosa, "A quantitative spatiotemporal analysis of microglia morphology during ischemic stroke and reperfusion," Journal of Neuroinflammation, vol. 10, article 4, 2013.
16. T. Shichita, M. Ito, and A. Yoshimura, "Post-ischemic inflammation regulates neural damage and protection," Frontiers in Cellular Neuroscience, vol. 8, article 319, 2014.
17. Q. Zhao, X. Xie, Y. Fan et al., "Phenotypic dysregulation of microglial activation in young offspring rats with maternal sleep deprivation-induced cognitive impairment," Scientific Reports, vol. 5, article 9513, 2015.
18. E. J. Walker and G. A. Rosenberg, "TIMP-3 and MMP-3 contribute to delayed inflammation and hippocampal neuronal death following global ischemia," Experimental Neurology, vol. 216, no. 1, pp. 122-131, 2009.
19. Y. Lee, S.-R. Lee, S. S. Choi, H.-G. Yeo, K.-T. Chang, and H. J. Lee, "Therapeutically targeting neuroinflammation and microglia after acute ischemic stroke," BioMed Research International, vol. 2014,Article ID 297241, 9 pages, 2014.
20. C.-L. Hsieh, C.-Y. Cheng, T.-H. Tsai et al., "Paeonol reduced cerebral infarction involving the superoxide anion and microglia activation in ischemia-reperfusion injured rats," Journal of Ethnopharmacology, vol. 106, no. 2, pp. 208-215, 2006.
21. S.-L. Liao, T.-K. Kao, W.-Y. Chen et al., "Tetramethylpyrazine reduces ischemic brain injury in rats," Neuroscience Letters, vol. 372, no. 1-2, pp. 40-45, 2004.
22. T.-K. Kao, Y.-C. Ou, J.-S. Kuo et al., "Neuroprotection by tetramethylpyrazine against ischemic brain injury in rats," Neurochemistry International, vol. 48, no. 3, pp. 166-176, 2006.
23. S. J. Chan, W. S. F. Wong, P. T. H. Wong, and J.-S. Bian, "Neuroprotective effects of andrographolide in a rat model of permanent cerebral ischaemia," British Journal of Pharmacology, vol. 161, no. 3, pp. 668-679, 2010.
24. C.-J. Lao, J.-G. Lin, J.-S. Kuo et al., "Microglia, apoptosis and interleukin-1β expression in the effect of Sophora Japonica L. on cerebral infarct induced by ischemia-reperfusion in rats," American Journal of Chinese Medicine, vol. 33, no. 3, pp. 425-438, 2005.
25. D.W. Lim, C. Lee, I.-H. Kim, and Y. T. Kim, "Anti-inflammatory effects of total isoflavones from Pueraria lobata on cerebral ischemia in rats,"Molecules, vol. 18,no. 9, pp. 10404-10412, 2013.
26. A. C. C. da Fonseca, D. Matias, C. Garcia et al., "The impact of microglial activation on blood-brain barrier in brain diseases," Frontiers in Cellular Neuroscience, vol. 8, article 362, 2014.
27. G. Trendelenburg, "Molecular regulation of cell fate in cerebral ischemia: role of the inflammasome and connected pathways," Journal of Cerebral Blood Flow &Metabolism, vol. 34, no. 12, pp. 1857-1867, 2014.
28. G. Yilmaz and D. N. Granger, "Leukocyte recruitment and ischemic brain injury," NeuroMolecular Medicine, vol. 12, no. 2, pp. 193-204, 2010.
29. J. Monteseirín, E. Llamas, H. Sánchez-Monteseirín et al., "IgEmediated downregulation of L-selectin (CD62L) on lymphocytes from asthmatic patients," Allergy, vol. 56, no. 2, pp. 164-168, 2001.
30. B. M. Famakin, "The immune response to acute focal cerebral ischemia and associated post-stroke immunodepression: a focused review," Aging and Disease, vol. 5, no. 5, pp. 307-326, 2014.
31. J.-S. Lu, J.-X. Liu, W.-Y. Zhang, S.-W. Liang, D. Wang, and J. Fang, "Preventive effects of Emodin on cerebral ischemia injury and expression of the inflammatory factors in rats with cerebral ischemia," Zhongguo Zhong Yao Za Zhi, vol. 30,no. 24,pp. 1939-1943, 2005.
32. C.-Y. Cheng, T.-Y. Ho, E.-J. Lee, S.-Y. Su, N.-Y. Tang, and C.-L. Hsieh, "Ferulic acid reduces cerebral infarct through its antioxidative and anti-inflammatory effects following transient focal cerebral ischemia in rats," The American Journal of Chinese Medicine, vol. 36, no. 6, pp. 1105-1119, 2008.
33. C.-Y.Cheng, S.-Y. Su,N.-Y. Tang, T.-Y.Ho, S.-Y.Chiang, and C.-L. Hsieh, "Ferulic acid provides neuroprotection against oxidative stress-related apoptosis after cerebral ischemia/reperfusion injury by inhibiting ICAM-1 mRNA expression in rats," Brain Research, vol. 1209, pp. 136-150, 2008.
34. H.-W. Wang, K.-T. Liou, Y.-H. Wang et al., "Deciphering the neuroprotective mechanisms of Bu-yang Huan-wu decoction by an integrative neurofunctional and genomic approach in ischemic stroke mice," Journal of Ethnopharmacology, vol. 138, no. 1, pp. 22-33, 2011.
35. M. S. Miao, X. X. Zhang, M. Bai, and L. N. Wang, "Persimmon leaf flavonoid promotes brain ischemic tolerance," Neural Regeneration Research, vol. 8, no. 28, pp. 2625-2632, 2013.
36. Z. Lin, D. Zhu, Y. Yan, and B. Yu, "Herbal formula FBD extracts prevented brain injury and inflammation induced by cerebral ischemia-reperfusion," Journal of Ethnopharmacology, vol. 118, no. 1, pp. 140-147, 2008.
37. Q.-X. Kong, Z.-Y. Wu, X. Chu, R.-Q. Liang, M. Xia, and L. Li, "Study on the anti-cerebral ischemia effect of borneol and its mechanism," African Journal of Traditional, Complementary, and Alternative Medicines, vol. 11, no. 1, pp. 161-164, 2014.
38. M. Lin, W. Sun, W. Gong, Z. Zhou, Y. Ding, and Q. Hou, "Methylophiopogonanone a protects against cerebral ischemia/reperfusion injury and attenuates blood-brain barrier disruption," PLoS ONE, vol. 10, no. 4, Article IDe0124558, 2015.
39. F. Tan,W. Fu, N. Cheng, D. I. Meng, and Y. Gu, "Ligustrazine reduces blood-brain barrier permeability in a rat model of focal cerebral ischemia and reperfusion," Experimental and Therapeutic Medicine, vol. 9, no. 5, pp. 1757-1762, 2015.
40. X.-W. Mao, C.-S. Pan, P. Huang et al., "Levotetrahydropalmatine attenuates mouse blood-brain barrier injury induced by focal cerebral ischemia and reperfusion: involvement of Src kinase," Scientific Reports, vol. 5, Article ID 11155, 2015.
41. F. Zhou, L.Wang, P. P. Liu et al., "Puerarin protects brain tissue against cerebral ischemia/reperfusion injury by inhibiting the inflammatory response," Neural Regeneration Research, vol. 9, no. 23, pp. 2074-2080, 2014.
42. C.-Y. Chang, T.-K. Kao,W.-Y. Chen et al., "Tetramethylpyrazine inhibits neutrophil activation following permanent cerebral ischemia in rats,"Biochemical andBiophysical ResearchCommunications, vol. 463, no. 3, pp. 421-427, 2015.
43. Y. H. Tang, S. P. Zhang, Y. Liang, and C. Q. Deng, "Effects of Panax notoginseng saponins on mRNA expressions of interleukin-1 β, its correlative factors and cysteinyl-aspartate specific protease after cerebral ischemia-reperfusion in rats," Zhong Xi Yi JieHe Xue Bao, vol. 5, no. 3, pp. 328-332, 2007.
44. Y. Chang, C.-Y. Hsieh, Z.-A. Peng et al., "Neuroprotective mechanisms of puerarin in middle cerebral artery occlusioninduced brain infarction in rats," Journal of Biomedical Science, vol. 16, article 9, 2009.
45. F. Li, Q. Gong, L. Wang, and J. Shi, "Osthole attenuates focal inflammatory reaction following permanent middle cerebral artery occlusion in rats,"Biological and Pharmaceutical Bulletin, vol. 35, no. 10, pp. 1686-1690, 2012.
46. S.-X. Wang, H. Guo, L.-M. Hu et al., "Caffeic acid ester fraction from erigeron breviscapus inhibits microglial activation and provides neuroprotection," Chinese Journal of Integrative Medicine, vol. 18, no. 6, pp. 437-444, 2012.
47. T. Fan, W. L. Jiang, J. Zhu, and Y. Feng Zhang, "Arctigenin protects focal cerebral ischemia-reperfusion rats through inhibiting neuroinflammation," Biological and Pharmaceutical Bulletin, vol. 35, no. 11, pp. 2004-2009, 2012.
48. T. H. Lee, C. H. Jung, and D.-H. Lee, "Neuroprotective effects of Schisandrin B against transient focal cerebral ischemia in Sprague-Dawley rats," Food and Chemical Toxicology, vol. 50, no. 12, pp. 4239-4245, 2012.
49. S. Chen, Z.-J. Yin, C. Jiang et al., "Asiaticoside attenuates memory impairment induced by transient cerebral ischemiareperfusion in mice through anti-inflammatory mechanism," Pharmacology Biochemistry and Behavior, vol. 122, pp. 7-15, 2014.
50. J.-H. Chen, H.-C. Kuo, K.-F. Lee, and T.-H. Tsai, "Magnolol protects neurons against ischemia injury via the downregulation of p38/MAPK, CHOP and nitrotyrosine," Toxicology and Applied Pharmacology, vol. 279, no. 3, pp. 294-302, 2014.
51. Z. Wang, F. Song, J. Li et al., "PET demonstrates functional recovery after treatment by danhong injection in a rat model of cerebral ischemic-reperfusion injury," Evidence-Based Complementary and Alternative Medicine, vol. 2014, Article ID 430757, 9 pages, 2014.
52. Z. Peng, S. Wang, G. Chen et al., "Gastrodin alleviates cerebral ischemic damage in mice by improving anti-oxidant and antiinflammation activities and inhibiting apoptosis pathway," Neurochemical Research, vol. 40, no. 4, pp. 661-673, 2015.
53. X.-Y. Liang, H.-N. Li, X.-Y. Yang, W.-Y. Zhou, J.-G. Niu, and B.-D. Chen, "Effect of Danshen aqueous extract on serum hs-CRP, IL-8, IL-10, TNF-α levels, and IL-10mRNA,TNF-αmRNA expression levels, cerebral TGF-β1 positive expression level and its neuroprotective mechanisms in CIR rats,"Molecular Biology Reports, vol. 40, no. 4, pp. 3419-3427, 2013.
54. T.-J. Li, Y. Qiu, J.-Q. Mao, P.-Y. Yang, Y.-C. Rui, and W.-S. Chen, "Protective effects of Guizhi-Fuling-capsules on rat brain ischemia/reperfusion injury," Journal of Pharmacological Sciences, vol. 105, no. 1, pp. 34-40, 2007.
55. Y. Zhang, S. Zhang, H. Li et al., "Ameliorative effects of Gualou Guizhi decoction on inflammation in focal cerebral ischemicreperfusion injury," Molecular Medicine Reports, vol. 12, no. 1, pp. 988-994, 2015.
56. R.-B. Guo, G.-F.Wang, A.-P. Zhao, J. Gu, X.-L. Sun, and G. Hu, "Paeoniflorin protects against ischemia-induced brain damages in rats via inhibiting MAPKs/NF-κB-mediated inflammatory responses," PLoS ONE, vol. 7, no. 11,Article ID e49701, 2012.
57. D.-M. Chen, L. Xiao, X. Cai, R. Zeng, and X.-Z. Zhu, "Involvement ofmultitargets in paeoniflorin-induced preconditioning," Journal of Pharmacology and Experimental Therapeutics, vol. 319, no. 1, pp. 165-180, 2006.
58. H. Lee, Y. O. Kim, H. Kim et al., "Flavonoid wogonin from medicinal herb is neuroprotective by inhibiting inflammatory activation of microglia," The FASEB Journal, vol. 17, no. 13, pp. 1943-1944, 2003.
59. B. Y. H. Lam, A. C. Y. Lo, X. Sun, H.W. Luo, S. K. Chung, andN. J. Sucher, "Neuroprotective effects of tanshinones in transient focal cerebral ischemia in mice," Phytomedicine, vol. 10, no. 4, pp. 286-291, 2003.
60. K.Dong, W. Xu, J. Yang, H. Qiao, and L. Wu, "Neuroprotective effects of Tanshinone IIA on permanent focal cerebral ischemia in mice," Phytotherapy Research, vol. 23,no. 5, pp.608-613,2009.
61. Y.-C. Hou, K.-T. Liou, C.-M. Chern et al., "Preventive effect of silymarin in cerebral ischemia-reperfusion-induced brain injury in rats possibly through impairing NF-κB and STAT-1 activation," Phytomedicine, vol. 17, no. 12, pp. 963-973, 2010.
62. T. Guan, Q. Liu, Y. Qian et al., "Ruscogenin reduces cerebral ischemic injury via NF-κB-mediated inflammatory pathway in the mouse model of experimental stroke," European Journal of Pharmacology, vol. 714, no. 1-3, pp. 303-311, 2013.
63. Y. Liu, Z. Lian, H. Zhu et al., "A systematic, integrated study on the neuroprotective effects of hydroxysafflor yellow a revealed by 1H NMR-based metabonomics and the NF-κB pathway," Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 147362, 14 pages, 2013.
64. C.-M. Chern, Y.-H. Wang, K.-T. Liou, Y.-C. Hou, C.-C. Chen, and Y.-C. Shen, "2-Methoxystypandrone ameliorates brain function through preserving BBB integrity and promoting neurogenesis in mice with acute ischemic stroke," Biochemical Pharmacology, vol. 87, no. 3, pp. 502-514, 2014.
65. T. Yang, S. Sun, T.Wang et al., "Piperlonguminine is neuroprotective in experimental rat stroke," International Immunopharmacology, vol. 23, no. 2, pp. 447-451, 2014.
66. Z.-J. Liu, W. Liu, L. Liu, C. Xiao, Y. Wang, and J.-S. Jiao, "Curcumin protects neuron against cerebral ischemia-induced inflammation through improving PPAR-gamma function," Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 470975, 10 pages, 2013.
67. D. Xiong, Y. Deng, B. Huang et al., "Icariin attenuates cerebral ischemia-reperfusion injury through inhibition of inflammatory response mediated by NF-κB, PPARα and PPARγ in rats," International Immunopharmacology, vol. 30, pp. 157-162, 2016.
68. L. Yu, C. Chen, L.-F. Wang et al., "Neuroprotective effect of kaempferol glycosides against brain injury and neuroinflammation by inhibiting the activation of NF-κB and STAT3 in transient focal stroke," PLoS ONE, vol. 8, no. 2, Article ID e55839, 2013.
69. X.-P. Huang, H. Ding, J.-D. Lu, Y.-H. Tang, B.-X. Deng, and C.-Q. Deng, "Effects of the combination of themain active components of Astragalus and Panax notoginseng on inflammation and apoptosis of nerve cell after cerebral ischemia-reperfusion," The American Journal of Chinese Medicine, vol. 43, no. 7, pp. 1419-1438, 2015.
70. L. Li, H. Li, and M. Li, "Curcumin protects against cerebral ischemia-reperfusion injury by activating JAK2/STAT3 signaling pathway in rats," International Journal of Clinical and Experimental Medicine, vol. 8, no. 9, pp. 14985-14991, 2015.
71. T.-K. Kao, C.-Y. Chang, Y.-C. Ou et al., "Tetramethylpyrazine reduces cellular inflammatory response following permanent focal cerebral ischemia in rats," Experimental Neurology, vol. 247, pp. 188-201, 2013.
72. H. Könnecke and I. Bechmann, "The role of microglia and matrix metalloproteinases involvement in neuroinflammation and gliomas," Clinical and Developmental Immunology, vol. 2013, Article ID 914104, 15 pages, 2013.
73. T. Shichita, R. Sakaguchi, M. Suzuki, and A. Yoshimura, "Postischemic inflammation in the brain," Frontiers in Immunology, vol. 3, article 132, 2012.
74. X. Dong, Y.-N. Song, W.-G. Liu, and X.-L. Guo, "MMP-9, a potential target for cerebral ischemic treatment," Current Neuropharmacology, vol. 7, no. 4, pp. 269-275, 2009.
75. A. M. Romanic, R. F. White, A. J. Arleth, E. H. Ohlstein, and F. C. Barone, "Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size," Stroke, vol. 29, no. 5, pp. 1020-1030, 1998.
76. S. E. Lakhan, A. Kirchgessner, D. Tepper, and A. Leonard, "Matrix metalloproteinases and blood-brain barrier disruption in acute ischemic stroke," Frontiers in Neurology, vol. 4, article 32, 2013.
77. Y.-M. Zhang, H. Xu, H. Sun, S.-H. Chen, and F.-M. Wang, "Electroacupuncture treatment improves neurological function associated with regulation of tight junction proteins in rats with cerebral ischemia reperfusion injury," Evidence-Based Complementary and AlternativeMedicine, vol. 2014, Article ID 989340, 10 pages, 2014.
78. H. Jiao, Z. Wang, Y. Liu, P. Wang, and Y. Xue, "Specific role of tight junction proteins claudin-5, occludin, and ZO-1 of the blood-brain barrier in a focal cerebral ischemic insult," Journal of Molecular Neuroscience, vol. 44, no. 2, pp. 130-139, 2011.
79. R. A. Taylor and L. H. Sansing, "Microglial responses after ischemic stroke and intracerebral hemorrhage," Clinical and Developmental Immunology, vol. 2013, Article ID 746068, 10 pages, 2013.
80. R. Barakat and Z. Redzic, "Differential cytokine expression by brain microglia/macrophages in primary culture after oxygen glucose deprivation and their protective effects on astrocytes during anoxia," Fluids and Barriers of the CNS, vol. 12, article 6, 2015.
81. Y.-C. Wang, S. Lin, and Q.-W. Yang, "Toll-like receptors in cerebral ischemic inflammatory injury," Journal of Neuroinflammation, vol. 8, article 134, 2011.
82. Y. Wang, P. Ge, and Y. Zhu, "TLR2 and TLR4 in the brain injury caused by cerebral ischemia and reperfusion," Mediators of Inflammation, vol. 2013,Article ID 124614, 8 pages, 2013.
83. X.-K. Tu, W.-Z. Yang, S.-S. Shi et al., "Spatio-temporal distribution of inflammatory reaction and expression of TLR2/4 signaling pathway in rat brain following permanent focal cerebral ischemia," Neurochemical Research, vol. 35, no. 8, pp. 1147-1155, 2010.
84. A. Maddahi, L. S. Kruse, Q.-W. Chen, and L. Edvinsson, "The role of tumor necrosis factor-α and TNF-α receptors in cerebral arteries following cerebral ischemia in rat," Journal of Neuroinflammation, vol. 8, article 107, 2011.
85. Q. Hua, X.-L. Zhu, P.-T. Li et al., "The inhibitory effects of cholalic acid and hyodeoxycholalic acid on the expression of TNFα and IL-1β after cerebral ischemia in rats," Archives of Pharmacal Research, vol. 32, no. 1, pp. 65-73, 2009.
86. W. Chadwick, T. Magnus, B. Martin, A. Keselman, M. P. Mattson, and S. Maudsley, "Targeting TNF-α receptors for neurotherapeutics," Trends in Neurosciences, vol. 31, no. 10, pp. 504-511, 2008.
87. A. Maddahi and L. Edvinsson, "Cerebral ischemia induces microvascular pro-inflammatory cytokine expression via the MEK/ERK pathway," Journal of Neuroinflammation, vol. 7, article 14, 2010.
88. H. Boutin, R. A. LeFeuvre, R. Horai, M. Asano, Y. Iwakura, and N. J. Rothwell, "Role of IL-1α and IL-1β in ischemic brain damage," The Journal of Neuroscience, vol. 21, no. 15, pp. 5528-5534, 2001.
89. G. P. Schielke, G.-Y. Yang, B. D. Shivers, and A. L. Betz, "Reduced ischemic brain injury in interleukin-1β converting enzyme-deficient mice," Journal of Cerebral Blood Flow and Metabolism, vol. 18, no. 2, pp. 180-185, 1998.
90. K.N.Murray, A. R. Parry-Jones, and S.M.Allan, "Interleukin-1 and acute brain injury," Frontiers in Cellular Neuroscience, vol. 9, article 18, 2015.
91. D. Acalovschi, T. Wiest, M. Hartmann et al., "Multiple levels of regulation of the interleukin-6 system in stroke," Stroke, vol. 34, no. 8, pp. 1864-1869, 2003.
92. E. Tarkowski, L. Rosengren, C. Blomstrand et al., "Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke," Stroke, vol. 26, no. 8, pp. 1393-1398, 1995.
93. T. Yamashita, K. Sawamoto, S. Suzuki et al., "Blockade of interleukin-6 signaling aggravates ischemic cerebral damage in mice: possible involvement of Stat3 activation in the protection of neurons," Journal of Neurochemistry, vol. 94, no. 2, pp. 459-468, 2005.
94. S. A. Loddick, A. V. Turnbull, and N. J. Rothwell, "Cerebral interleukin-6 is neuroprotective during permanent focal cerebral ischemia in the rat," Journal of Cerebral Blood Flow & Metabolism, vol. 18, no. 2, pp. 176-179, 1998.
95. M. Hedtjärn, A.-L. Leverin, K. Eriksson, K. Blomgren, C. Mallard, and H. Hagberg, "Interleukin-18 involvement in hypoxicischemic brain injury," The Journal of Neuroscience, vol. 22, no. 14, pp. 5910-5919, 2002.
96. F. M. Domac and H. Misirli, "The role of neutrophils and interleukin-8 in acute ischemic stroke," Neurosciences, vol. 13, no. 2, pp. 136-141, 2008.
97. S. Jander,M. Schroeter, and G. Stoll, "Interleukin-18 expression after focal ischemia of the rat brain: association with the latestage inflammatory response," Journal of Cerebral Blood Flow & Metabolism, vol. 22, no. 1, pp. 62-70, 2002.
98. K. L. Lambertsen, R. Gregersen,M.Meldgaard et al., "A role for interferon-gamma in focal cerebral ischemia in mice," Journal of Neuropathology and Experimental Neurology, vol. 63, no. 9, pp. 942-955, 2004.
99. C.Marie,C. Pitton, C. Fitting, and J.-M.Cavaillon, "Regulation by anti-inflammatory cytokines (IL-4, IL-10, IL-13, TGFβ)of interleukin-8 production by LPS-and/ or TNFα-activated human polymorphonuclear cells," Mediators of Inflammation, vol. 5, no. 5, pp. 334-340, 1996.
100. X. Liu, J. Liu, S. Zhao et al., "Interleukin-4 is essential for microglia/macrophageM2polarization and long-termrecovery after cerebral ischemia," Stroke, vol. 47, no. 2, pp. 498-504, 2016.
101. N. Liu, R. Chen, H. Du, J. Wang, Y. Zhang, and J. Wen, "Expression of IL-10 and TNF-α in rats with cerebral infarction after transplantationwithmesenchymal stem cells,"Cellular and Molecular Immunology, vol. 6, no. 3, pp. 207-213, 2009.
102. X. Zhao, H. Wang, G. Sun, J. Zhang, N. J. Edwards, and J. Aronowski, "Neuronal interleukin-4 as a modulator of microglial pathways and ischemic brain damage," The Journal of Neuroscience, vol. 35, no. 32, pp. 11281-11291, 2015.
103. L.-S. Chu, S.-H. Fang, Y. Zhou et al., "Minocycline inhibits 5-lipoxygenase activation and brain inflammation after focal cerebral ischemia in rats," Acta Pharmacologica Sinica, vol. 28, no. 6, pp. 763-772, 2007.
104. D. A. Ridder and M. Schwaninger, "NF-κB signaling in cerebral ischemia," Neuroscience, vol. 158, no. 3, pp. 995-1006, 2009.
105. A. Oeckinghaus and S. Ghosh, "The NF-kappaB family of transcription factors and its regulation," Cold Spring Harbor Perspectives in Biology, vol. 1, no. 4, article a000034, 2009.
106. F. Wan and M. J. Lenardo, "Specification of DNA binding activity ofNF-kappaB proteins," Cold SpringHarbor Perspectives in Biology, vol. 1, no. 4, Article ID a000067, 2009.
107. R. Berti, A. J. Williams, J. R. Moffett et al., "Quantitative real-time RT-PCR analysis of inflammatory gene expression associated with ischemia-reperfusion brain injury," Journal of Cerebral Blood Flow and Metabolism, vol. 22, no. 9, pp. 1068-1079, 2002.
108. M. Jiang, J. Li, Q. Peng et al., "Neuroprotective effects of bilobalide on cerebral ischemia and reperfusion injury are associated with inhibition of pro-inflammatory mediator production and down-regulation of JNK1/2 and p38MAPK activation," Journal of Neuroinflammation, vol. 11, article 167, pp. 1-17, 2014.
109. L.Wang, Z. Li, X. Zhang et al., "Protective effect of shikonin in experimental ischemic stroke: attenuated TLR4, p-p38MAPK, NF-κB, TNF-α and MMP-9 expression, up-regulated claudin-5 expression, ameliorated BBB permeability," Neurochemical Research, vol. 39, no. 1, pp. 97-106, 2014.
110. H. Liu, X.Wei, L. Kong et al., "NOD2 is involved in the inflammatory response after cerebral ischemia-reperfusion injury and triggers NADPH oxidase 2-derived reactive oxygen species," International Journal of Biological Sciences, vol. 11,no. 5, pp. 525-535, 2015.
111. J.-H. Yi, S.-W. Park, R. Kapadia, and R. Vemuganti, "Role of transcription factors in mediating post-ischemic cerebral inflammation and brain damage," Neurochemistry International, vol. 50, no. 7-8, pp. 1014-1027, 2007.
112. S. Dziennis and N. J. Alkayed, "Role of signal transducer and activator of transcription 3 in neuronal survival and regeneration," Reviews in the Neurosciences, vol. 19, no. 4-5, pp. 341-361, 2008.
113. S. Dziennis, T. Jia, O. K. Rønnekleiv, P. D. Hurn, and N. J. Alkayed, "Role of signal transducer and activator of transcription-3 in estradiol-mediated neuroprotection," The Journal of Neuroscience, vol. 27, no. 27, pp. 7268-7274, 2007.
114. X. Wang, Q. Liu, A. Ihsan et al., "JAK/STAT pathway plays a critical role in the proinflammatory gene expression and apoptosis of RAW264.7 cells induced by trichothecenes as don and T-2 toxin," Toxicological Sciences, vol. 127, no. 2,pp. 412-424, 2012.
115. C. Schindler, D. E. Levy, and T. Decker, "JAK-STAT signaling: from interferons to cytokines,"The Journal of Biological Chemistry, vol. 282, no. 28, pp. 20059-20063, 2007.
116. C. Lei, J. Deng, B. Wang et al., "Reactive oxygen species scavenger inhibits STAT3 activation after transient focal cerebral ischemia-reperfusion injury in rats," Anesthesia & Analgesia, vol. 113, no. 1, pp. 153-159, 2011.
117. H.Zhu, L.Zou, J.Tian, G. Du, and Y. Gao, "SMND-309, a novel derivative of salvianolic acid B, protects rat brains ischemia and reperfusion injury by targeting the JAK2/STAT3 pathway," European Journal of Pharmacology, vol. 714, no. 1-3, pp. 23-31, 2013.
118. L. Li, X. Zhang, L. Cui et al., "Ursolic acid promotes the neuroprotection by activatingNrf2 pathway after cerebral ischemia in mice," Brain Research, vol. 1497, pp. 32-39, 2013.
119. M. Li, X. Zhang, L. Cui et al., "The neuroprotection of oxymatrine in cerebral ischemia/reperfusion is related to nuclear factor erythroid 2-related factor 2 (Nrf2)-mediated antioxidant response: role of Nrf2 and hemeoxygenase-1 expression," Biological and Pharmaceutical Bulletin, vol. 34, no. 5, pp. 595-601, 2011.
120. Y. Dong, H. D. Liu, R. Zhao et al., "Ischemia activates JNK/c-Jun/AP-1 pathway to up-regulate 14-3-3γ in astrocyte," Journal of Neurochemistry, vol. 109, supplement 1, pp. 182-188, 2009.